why choose us

First received: October 17, 2026

Clinical Trial: Long-Term Cardiovascular Impact of ArmoLIPID Cholesterol Plus: An In Silico Study Using Digital Twins

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Hypercholesterolemia
Cardiovascular Risk

Study Type: OBSERVATIONAL


Official Title: Long-Term Cardiovascular Impact of the New ArmoLIPID Cholesterol Plus Formulation: An In Silico Clinical Study Using 100,000 Digital Twins

Brief Summary: The goal of this study, conducted entirely using computer simulations, is to evaluate the projected long-term cardiovascular impact of the new ArmoLIPID Cholesterol Plus formulation in adults with mild-to-moderate hypercholesterolemia and low-to-moderate cardiovascular risk.The main questions this study aims to answer are:* Does the addition of ArmoLIPID Cholesterol Plus to lifestyle management reduce the projected incidence of major adverse cardiovascular events (MACE), including cardiovascular death, non-fatal…

Read more